ABVC BioPharma, Inc. Accounts Payable and Other Accrued Liabilities, Current
ABVC BioPharma, Inc. (ABVC) had Accounts Payable and Other Accrued Liabilities, Current of $4.20 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable and Other Accrued Liabilities, Current $4.20M.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities, Current $4.15M.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $4.16M.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $3.99M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.20M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $4.15M 10-Q · filed 2026-05-18 | |
| 2025-12-31 | $4.16M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $3.99M 10-Q/A · filed 2026-03-03 | |
| 2025-06-30 | $4.29M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $3.83M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $3.51M 10-Q/A · filed 2026-03-03 | |
| 2024-09-30 | $3.59M 10-Q/A · filed 2026-03-03 | $3.63M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.63M 10-Q · filed 2025-08-13 | $3.96M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $3.45M 10-Q · filed 2025-04-30 | $4.05M 10-Q · filed 2024-05-17 |
| 2023-12-31 | $3.55M 10-K · filed 2025-04-15 | $3.70M 10-Q · filed 2024-05-17 |
| 2021-03-31 | $44.10K 10-Q · filed 2021-05-10 | |
| 2015-09-30 | $300.00K 10-Q · filed 2016-05-17 |